Clinical Trials List
Protocol Number一項為期 6 週、多中心、隨機、雙盲、安慰劑對照之第二期研究，以評估每日口服一次 OPC-34712，和每日口服一次 Aripiprazole 對住院治療的急性精神分裂症成年患者的療效、安全性和耐受性
2009-11-01 - 2010-10-31
Phase II
Terminated3
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 梁珪瑜 Division of Psychiatry
- 葉紅秀 Division of Psychiatry
- Tzu-Ting Chen Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林世棋 Division of Psychiatry
- 郭兆展 Division of Psychiatry
- mei feng Huang Division of Psychiatry
- 林清華 Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
450 participants
